Corteva, Inc. (NYSE:CTVA) Shares Sold by Natixis

Natixis reduced its stake in Corteva, Inc. (NYSE:CTVA - Free Report) by 24.5% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 33,358 shares of the company's stock after selling 10,845 shares during the period. Natixis' holdings in Corteva were worth $1,900,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Oak Thistle LLC acquired a new position in Corteva in the fourth quarter valued at $1,514,000. Van ECK Associates Corp increased its position in Corteva by 5.9% during the fourth quarter. Van ECK Associates Corp now owns 9,428,206 shares of the company's stock worth $537,031,000 after buying an additional 525,531 shares during the period. Swedbank AB lifted its stake in Corteva by 51.9% in the fourth quarter. Swedbank AB now owns 695,641 shares of the company's stock valued at $39,624,000 after buying an additional 237,764 shares during the last quarter. Assenagon Asset Management S.A. boosted its holdings in shares of Corteva by 755.8% in the fourth quarter. Assenagon Asset Management S.A. now owns 552,769 shares of the company's stock valued at $31,486,000 after acquiring an additional 488,181 shares during the period. Finally, S.E.E.D. Planning Group LLC increased its holdings in shares of Corteva by 54.5% in the 4th quarter. S.E.E.D. Planning Group LLC now owns 96,103 shares of the company's stock valued at $5,474,000 after acquiring an additional 33,886 shares during the period. Institutional investors and hedge funds own 81.54% of the company's stock.

Corteva Trading Up 0.1 %

NYSE CTVA traded up $0.09 during mid-day trading on Monday, reaching $61.56. 612,000 shares of the stock were exchanged, compared to its average volume of 3,314,894. The stock has a market capitalization of $42.05 billion, a PE ratio of 47.74, a PEG ratio of 1.68 and a beta of 0.73. The company has a debt-to-equity ratio of 0.08, a quick ratio of 0.93 and a current ratio of 1.45. Corteva, Inc. has a 1-year low of $50.01 and a 1-year high of $66.24. The business's fifty day simple moving average is $60.71 and its 200 day simple moving average is $60.44.

Corteva (NYSE:CTVA - Get Free Report) last posted its quarterly earnings results on Wednesday, February 5th. The company reported $0.32 EPS for the quarter, missing the consensus estimate of $0.34 by ($0.02). Corteva had a net margin of 5.36% and a return on equity of 7.19%. On average, research analysts anticipate that Corteva, Inc. will post 2.96 earnings per share for the current fiscal year.

Insider Buying and Selling at Corteva

In other news, insider Brian Titus sold 26,560 shares of the stock in a transaction on Thursday, February 20th. The shares were sold at an average price of $63.74, for a total value of $1,692,934.40. Following the completion of the sale, the insider now owns 11,347 shares of the company's stock, valued at $723,257.78. This represents a 70.07 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.14% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research firms recently issued reports on CTVA. Oppenheimer raised their price target on Corteva from $70.00 to $72.00 and gave the stock an "outperform" rating in a report on Friday, February 7th. Wells Fargo & Company increased their price target on Corteva from $67.00 to $73.00 and gave the stock an "overweight" rating in a report on Tuesday, January 28th. Argus raised shares of Corteva from a "hold" rating to a "buy" rating and set a $69.00 price target for the company in a report on Monday, March 31st. Barclays lifted their price target on Corteva from $62.00 to $64.00 and gave the company an "equal weight" rating in a research note on Tuesday, January 21st. Finally, The Goldman Sachs Group started coverage on Corteva in a research report on Thursday, March 13th. They issued a "buy" rating and a $71.00 price objective for the company. One analyst has rated the stock with a sell rating, three have assigned a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat.com, Corteva presently has an average rating of "Moderate Buy" and a consensus target price of $68.13.

Corteva Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.